Published in J Biol Chem on October 09, 2008
Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol (2011) 2.96
Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci U S A (2013) 1.39
Angiogenesis. Cold Spring Harb Perspect Biol (2011) 1.37
Extracellular matrix as an inductive scaffold for functional tissue reconstruction. Transl Res (2013) 1.09
Matricryptic sites control tissue injury responses in the cardiovascular system: relationships to pattern recognition receptor regulated events. J Mol Cell Cardiol (2009) 1.08
PDGF-A interactions with fibronectin reveal a critical role for heparan sulfate in directed cell migration during Xenopus gastrulation. Proc Natl Acad Sci U S A (2009) 0.97
Pentosan polysulfate increases affinity between ADAMTS-5 and TIMP-3 through formation of an electrostatically driven trimolecular complex. Biochem J (2012) 0.87
The first type III repeat in fibronectin activates an inflammatory pathway in dermal fibroblasts. J Biol Chem (2010) 0.87
Fibronectin conformation regulates the proangiogenic capability of tumor-associated adipogenic stromal cells. Biochim Biophys Acta (2013) 0.85
Anchoring of vascular endothelial growth factor to surface-immobilized heparin on pancreatic islets: implications for stimulating islet angiogenesis. Tissue Eng Part A (2010) 0.84
Heparin-dependent regulation of fibronectin matrix conformation. Matrix Biol (2013) 0.83
Specific sides to multifaceted glycosaminoglycans are observed in embryonic development. Semin Cell Dev Biol (2010) 0.82
Sweet cues: How heparan sulfate modification of fibronectin enables growth factor guided migration of embryonic cells. Cell Adh Migr (2011) 0.82
Regulation of the innate immune response by fibronectin: synergism between the III-1 and EDA domains. PLoS One (2014) 0.80
Extracellular matrix modulates angiogenesis in physiological and pathological conditions. Biomed Res Int (2014) 0.80
No-reflow phenomenon and endothelial glycocalyx of microcirculation. Biochem Res Int (2011) 0.80
Fibronectin binding modulates CXCL11 activity and facilitates wound healing. PLoS One (2013) 0.80
Complex receptor-ligand dynamics control the response of the VEGF system to protease injury. BMC Syst Biol (2011) 0.78
Characterization of a multilayer heparin coating for biomolecule presentation to human mesenchymal stem cell spheroids. Biomater Sci (2014) 0.77
Collagen-gelatin mixtures as wound model, and substrates for VEGF-mimetic peptide binding and endothelial cell activation. Acta Biomater (2015) 0.76
Extracellular matrix stiffness modulates VEGF calcium signaling in endothelial cells: individual cell and population analysis. Integr Biol (Camb) (2015) 0.76
Thrombospondin-1 and microRNA-1 expression in response to multiwalled carbon nanotubes in alveolar epithelial cells. Environ Toxicol (2017) 0.75
Sulfated hyaluronan alters fibronectin matrix assembly and promotes osteogenic differentiation of human bone marrow stromal cells. Sci Rep (2016) 0.75
Physics of chemoreception. Biophys J (1977) 15.69
Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev (2005) 9.62
Mast cells. Physiol Rev (1997) 6.51
Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol (2000) 3.18
Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J (1999) 2.92
Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature (1999) 2.82
Heparin is essential for the storage of specific granule proteases in mast cells. Nature (1999) 2.34
Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med (1980) 2.27
Glycomics: an integrated systems approach to structure-function relationships of glycans. Nat Methods (2005) 2.06
Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest (1997) 1.89
Glycomics approach to structure-function relationships of glycosaminoglycans. Annu Rev Biomed Eng (2006) 1.89
Conformation and dynamics of heparin and heparan sulfate. Glycobiology (2000) 1.88
Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. Glycobiology (2004) 1.83
Fibroblast growth factor-2. Int J Biochem Cell Biol (2000) 1.80
Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res (2002) 1.76
Heparin and heparan sulfate: biosynthesis, structure and function. Curr Opin Chem Biol (2000) 1.75
The effect of receptor density on the forward rate constant for binding of ligands to cell surface receptors. Biophys J (1987) 1.65
Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation. EMBO J (2006) 1.59
Delayed clearance of transmitter and the role of glutamate transporters at synapses with multiple release sites. J Neurosci (1996) 1.59
Fibronectin in extended and compact conformations. Electron microscopy and sedimentation analysis. J Biol Chem (1983) 1.58
Conformational states of fibronectin. Effects of pH, ionic strength, and collagen binding. J Biol Chem (1982) 1.52
The complex effects of heparins on cancer progression and metastasis in experimental studies. Pharmacol Rev (2001) 1.51
The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer (1994) 1.51
Mast cells in neoangiogenesis. Med Sci Monit (2006) 1.50
Competition between solution and cell surface receptors for ligand. Dissociation of hapten bound to surface antibody in the presence of solution antibody. Biophys J (1989) 1.47
Theory for ligand rebinding at cell membrane surfaces. Biophys J (1998) 1.37
Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. J Invest Dermatol (1982) 1.35
Structure and function of fibronectin modules. Matrix Biol (1996) 1.34
Dependence of the shape of the plasma fibronectin molecule on solvent composition. Ionic strength and glycerol content. J Biol Chem (1983) 1.28
A catalytic role for heparin. Evidence for a ternary complex of heparin cofactor thrombin and heparin. Biochim Biophys Acta (1978) 1.28
Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. J Vasc Surg (2004) 1.27
Heparan sulfate-protein interactions: therapeutic potential through structure-function insights. Cell Mol Life Sci (2005) 1.20
Interaction of heparin with fibronectin and isolated fibronectin domains. Biochem J (1990) 1.20
Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. J Cell Biochem (1999) 1.19
Mast cells and cutaneous malignancies. Mod Pathol (2006) 1.17
Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry (2006) 1.16
Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: stoichiometry, stabilization, and kinetics. Biochemistry (1996) 1.14
pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release. J Biol Chem (2003) 1.13
Heparan sulphate. Int J Biochem Cell Biol (1997) 1.12
Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts. BMC Cancer (2005) 1.10
Crystal structure of antithrombin in a heparin-bound intermediate state. Biochemistry (2003) 1.09
Heparin and cancer. Thromb Haemost (1998) 1.06
Secondary structure of human plasma fibronectin: conformational change induced by calf alveolar heparan sulfates. Biochemistry (1985) 1.05
Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J Biol Chem (2003) 1.03
Bivalent ligand dissociation kinetics from receptor-bound immunoglobulin E: evidence for a time-dependent increase in ligand rebinding at the cell surface. Biochemistry (1991) 1.03
Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells. Mol Cell Biochem (2001) 1.03
Effects of receptor clustering on ligand dissociation kinetics: theory and simulations. Biophys J (2005) 1.02
Mapping the heparin-binding site on the 13-14F3 fragment of fibronectin. J Biol Chem (2002) 1.00
A method for the non-covalent immobilization of heparin to surfaces. Anal Biochem (2004) 1.00
VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells. Oncogene (2001) 0.97
A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin. J Biol Chem (1983) 0.94
Mast cells in invasive ductal breast cancer: different behavior in high and minimum hormone-receptive cancers. Anticancer Res (2007) 0.90
Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy. Cancer Lett (2002) 0.88
Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin. Biochem J (1981) 0.87
Ligand rebinding: self-consistent mean-field theory and numerical simulations applied to surface plasmon resonance studies. Eur Biophys J (2005) 0.86
Binding of heparin by type III domains and peptides from the carboxy terminal hep-2 region of fibronectin. Biochemistry (1993) 0.86
Heparins and heparinoids: occurrence, structure and mechanism of antithrombotic and hemorrhagic activities. Curr Pharm Des (2004) 0.83
Non-anticoagulant effects of heparin in carcinoma metastasis and Trousseau's syndrome. Pathophysiol Haemost Thromb (2003) 0.82
The catalysis by heparin of the reaction between thrombin and antithrombin. Biochim Biophys Acta (1986) 0.79
14 heparin-null transgenic mice are unable to store certain granule proteases in their mast cells J Histochem Cytochem (1999) 0.78
Aggregation and fibril formation of plasma fibronectin by heparin. Biol Chem Hoppe Seyler (1985) 0.77
Heparin binding to monodisperse plasma fibronectin induces aggregation without large-scale changes in conformation in solution. Int J Biol Macromol (1994) 0.76
Heparan sulfate-FGF10 interactions during lung morphogenesis. Dev Biol (2003) 1.24
Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry (2006) 1.16
pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release. J Biol Chem (2003) 1.13
Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circ Res (2003) 1.13
Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-beta signaling pathway. Circ Res (2008) 1.11
Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling. J Cell Biochem (2003) 1.09
The steady-state distribution of glycosyltransferases between the Golgi apparatus and the endoplasmic reticulum is approximately 90:10. Traffic (2005) 1.08
Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J Biol Chem (2003) 1.03
Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts. J Biol Chem (2010) 1.03
Effects of receptor clustering on ligand dissociation kinetics: theory and simulations. Biophys J (2005) 1.02
Inhibition of histone acetyltransferase by glycosaminoglycans. J Cell Biochem (2008) 1.00
Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism. Biochem J (2004) 1.00
Control of growth factor networks by heparan sulfate proteoglycans. Ann Biomed Eng (2008) 0.99
Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions. J Biol Chem (2011) 0.99
Heparan sulfate depletion within pulmonary fibroblasts: implications for elastogenesis and repair. J Cell Physiol (2002) 0.98
Elastase mediates the release of growth factors from lung in vivo. Am J Respir Cell Mol Biol (2004) 0.98
PDGF-A interactions with fibronectin reveal a critical role for heparan sulfate in directed cell migration during Xenopus gastrulation. Proc Natl Acad Sci U S A (2009) 0.97
Effects of elastase on the mechanical and failure properties of engineered elastin-rich matrices. J Appl Physiol (1985) (2005) 0.97
Heparan sulfates expressed in the distal lung are required for Fgf10 binding to the epithelium and for airway branching. Am J Physiol Lung Cell Mol Physiol (2003) 0.95
Cell-cell interactions mediate the response of vascular smooth muscle cells to substrate stiffness. Biophys J (2011) 0.95
The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling. J Theor Biol (2004) 0.95
A zipper network model of the failure mechanics of extracellular matrices. Proc Natl Acad Sci U S A (2009) 0.94
Lysyl oxidase oxidizes basic fibroblast growth factor and inactivates its mitogenic potential. J Cell Biochem (2003) 0.93
Binding inhibition of angiogenic factors by heparan sulfate proteoglycans in aqueous humor: potential mechanism for maintenance of an avascular environment. FASEB J (2003) 0.92
Elastase-released epidermal growth factor recruits epidermal growth factor receptor and extracellular signal-regulated kinases to down-regulate tropoelastin mRNA in lung fibroblasts. J Biol Chem (2002) 0.92
Neutrophil elastase cleaves VEGF to generate a VEGF fragment with altered activity. Am J Physiol Lung Cell Mol Physiol (2009) 0.92
In silico modeling of interstitial lung mechanics: implications for disease development and repair. Drug Discov Today Dis Models (2007) 0.91
Both post-Golgi and intra-Golgi cycling affect the distribution of the Golgi phosphoprotein GPP130. Traffic (2007) 0.90
Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans. Biochemistry (2005) 0.90
New insights into the inhibition of human neutrophil elastase by heparin. Biochemistry (2006) 0.88
Using quantitative fluorescence microscopy to probe organelle assembly and membrane trafficking. Methods Mol Biol (2008) 0.87
Ligand rebinding: self-consistent mean-field theory and numerical simulations applied to surface plasmon resonance studies. Eur Biophys J (2005) 0.86
Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenografts. PLoS One (2012) 0.86
Regulation of insulin-like growth factor-I (IGF-I) delivery by IGF binding proteins and receptors. Ann Biomed Eng (2006) 0.85
Self-consistent theory of reversible ligand binding to a spherical cell. Phys Biol (2008) 0.85
Extraction and purification of decorin from corneal stroma retain structure and biological activity. Protein Expr Purif (2002) 0.84
EGF antagonizes TGF-beta-induced tropoelastin expression in lung fibroblasts via stabilization of Smad corepressor TGIF. Am J Physiol Lung Cell Mol Physiol (2008) 0.83
Neutrophil elastase-initiated EGFR/MEK/ERK signaling counteracts stabilizing effect of autocrine TGF-beta on tropoelastin mRNA in lung fibroblasts. Am J Physiol Lung Cell Mol Physiol (2006) 0.83
Design and application of an oscillatory compression device for cell constructs. Biotechnol Bioeng (2007) 0.83
Heparin-binding EGF-like growth factor regulates elastin and FGF-2 expression in pulmonary fibroblasts. Am J Physiol Lung Cell Mol Physiol (2003) 0.82
Chronic pulsatile shear stress alters insulin-like growth factor-I (IGF-I) binding protein release in vitro. Ann Biomed Eng (2003) 0.82
Sweet cues: How heparan sulfate modification of fibronectin enables growth factor guided migration of embryonic cells. Cell Adh Migr (2011) 0.82
Dynamics of enzymatic digestion of elastic fibers and networks under tension. Proc Natl Acad Sci U S A (2011) 0.82
Ligand-induced coupling versus receptor pre-association: cellular automaton simulations of FGF-2 binding. J Theor Biol (2004) 0.81
A human surfactant peptide-elastase inhibitor construct as a treatment for emphysema. Proc Natl Acad Sci U S A (2010) 0.81
Docking server for the identification of heparin binding sites on proteins. J Chem Inf Model (2014) 0.81
A computational approach for deciphering the organization of glycosaminoglycans. PLoS One (2010) 0.81
Autocrine production of insulin-like growth factor-I (IGF-I) affects paracellular transport across epithelial cells in vitro. Cell Commun Adhes (2007) 0.79
Microtubule catastrophe from protofilament dynamics. Phys Rev E Stat Nonlin Soft Matter Phys (2013) 0.79
Effectiveness of a dynein team in a tug of war helped by reduced load sensitivity of detachment: evidence from the study of bidirectional endosome transport in D. discoideum. Phys Biol (2012) 0.79
Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth. J Cell Physiol (2008) 0.78
Complex receptor-ligand dynamics control the response of the VEGF system to protease injury. BMC Syst Biol (2011) 0.78
Theoretical results for chemotactic response and drift of E. coli in a weak attractant gradient. J Theor Biol (2010) 0.78
Ascorbate enhances elastin synthesis in 3D tissue-engineered pulmonary fibroblasts constructs. Tissue Cell (2013) 0.77
A computational model of FGF-2 binding and HSPG regulation under flow. IEEE Trans Biomed Eng (2008) 0.77
Chronic pulsatile shear stress impacts synthesis of proteoglycans by endothelial cells: effect on platelet aggregation and coagulation. J Cell Biochem (2002) 0.77
Transcriptional and proteolytic regulation of the insulin-like growth factor-I system of equine articular chondrocytes by recombinant equine interleukin-1beta. J Cell Physiol (2006) 0.76
Facilitated diffusion of VEGF165 through descemet's membrane with sucrose octasulfate. J Cell Physiol (2012) 0.76
Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways. J Biol Chem (2013) 0.76
Extracellular matrix stiffness modulates VEGF calcium signaling in endothelial cells: individual cell and population analysis. Integr Biol (Camb) (2015) 0.76
Alginate encapsulation impacts the insulin-like growth factor-I system of monolayer-expanded equine articular chondrocytes and cell response to interleukin-1beta. Tissue Eng (2007) 0.76
Endothelial cell capture of heparin-binding growth factors under flow. PLoS Comput Biol (2010) 0.75
Genetically engineered mouse melanoma and mouse Lewis lung carcinoma models. Int J Oncol (2005) 0.75
Memory, bias, and correlations in bidirectional transport of molecular-motor-driven cargoes. Phys Rev E Stat Nonlin Soft Matter Phys (2013) 0.75
Ligand-receptor binding kinetics in surface plasmon resonance cells: a Monte Carlo analysis. Phys Biol (2016) 0.75
Implementation of an optical method for the real-time determination of uniaxial strain and vessel mechanics. IEEE Trans Biomed Eng (2004) 0.75
Transcriptional regulation of pulmonary elastin gene expression in elastase-induced injury. Am J Physiol Lung Cell Mol Physiol (2003) 0.75